Actively Recruiting

Phase Not Applicable
Age: 30Years - 75Years
All Genders
NCT06382259

The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes.

Led by University of British Columbia · Updated on 2024-05-08

30

Participants Needed

1

Research Sites

63 weeks

Total Duration

On this page

Sponsors

U

University of British Columbia

Lead Sponsor

M

McMaster University

Collaborating Sponsor

AI-Summary

What this Trial Is About

To conduct a randomized crossover trial to determine the acute impact of low-intensity movement breaks on glycemic control in physically inactive individuals living with type 2 diabetes using continuous glucose monitoring.

CONDITIONS

Official Title

The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes.

Who Can Participate

Age: 30Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 30-75 years old.
  • Have physician-diagnosed type 2 diabetes.
  • Currently participating in less than 150 minutes of moderate-to-vigorous intensity aerobic exercise per week.
  • Have a body mass index between 18.5 and 40 kg/m2.
  • Have had a stable medication dosage and no changes to the number of prescribed medications for at least 6 months.
  • Able to maintain current medication doses during the study.
  • Able to maintain current physical activity patterns during the study.
  • HbA1c is less than or equal to 8.5%.
  • Have access to a computer, tablet, or smartphone for intervention delivery and tracking.
  • Can travel to McMaster University for in-person laboratory testing visits.
  • Can read, write, and understand English.
  • Anticipate having access to the internet for the duration of the intervention (i.e., over the next 3-4 months).
  • Cleared for exercise participation based on the CSEP Get Active Questionnaire and the Rose Angina Questionnaire.
Not Eligible

You will not qualify if you...

  • Taking 4 or more glucose-lowering medications.
  • Taking insulin.
  • Taking beta-blockers.
  • Taking 3 or more commonly prescribed medications for the prevention of cardiovascular disease (e.g., statins, antihypertensives).
  • Have had an episode of severe hypoglycemia in the past 6 months requiring assistance.
  • Currently a cigarette smoker.
  • Have a chronic musculoskeletal condition preventing exercise participation.
  • Have had a recent cardiovascular event within the last 2 years preventing exercise.
  • Experience angina upon exertion.
  • Have uncontrolled high blood pressure or abnormal blood pressure or pulse rate at rest or during exercise.
  • Have a scheduled surgery within the next 3-4 months preventing exercise.
  • Currently diagnosed with cardiac or pulmonary diseases preventing exercise.
  • Have a psychiatric disorder that could prevent completing study procedures.
  • Have donated more than 0.5 L of blood in the last 4 weeks.
  • Currently following an extreme diet or taking supplements affecting glucose control.
  • Have diabetic ulcers, peripheral vascular disease, or diabetic neuropathy preventing exercise.
  • Currently on dialysis.
  • Participating in another clinical trial interfering with this study.
  • Currently pregnant or planning pregnancy during the intervention period.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of British Columbia Okanagan

Kelowna, British Columbia, Canada, V1V 3G1

Actively Recruiting

Loading map...

Research Team

J

Jonathan P Little, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes. | DecenTrialz